CBD - It's Everywhere!

Join patient co-hosts Tiffany from AiArthritis and Bridget from the Canna-Patient Resource as they openly discuss the various types of cannabis - CBD products specifically - including potential legal issues, drug interactions, and how to safely incorporate CBD into your treatment plan. CBD is EVERYWHERE! What do you need to know?


LISTEN TO THE EPISODE THEN BE SURE TO TAKE A SEAT AT THE TABLE BY JOINING THE CONVERSATION! 

(Scroll down the page to learn how!)

You can find, follow, and listen on Podbean, Spotify, Apple Podcast, or where ever you do podcasts. Please follow, rate, and subscribe to the show, then share it with someone. Be sure to check out our top-rated show on Feedspot!

Pull up your seat at the table

Now it's YOUR TURN to join the conversation!

What do you think about this episode?

We want to know what you think! By continuing the conversation with your opinions and perspectives - we all get a better understanding of the problems facing our community.  Better yet, through these conversations we can start working and developing solutions.


We mean it when say 360. Not only do we want your input anytime and anywhere, but we also are eager to see where the conversation will take us. So please, "pull up a seat at the table" and let's start talking!


Email us at podcast@aiarthritis.org, message us on social media (find us by searching for @IFAiArthritis)

Continue the conversation in our own AiArthritis Voices 360 Talk Show Group!

Pull up a seat and join the conversation on the topic from today and past episodes. You may even get an opportunity to talk directly with the co-hosts and any episode guests!

The AiArthritis Voices Program

Our AiArthritis Voices 360 Talk Show is just a piece of larger program - the AiArthritis Voices Program.


AiArthritis Voices is our program where people living with AiArthritis diseases and other stakeholders who we need 'at the table' to solve problems that impact education, advocacy, and research sign up to have a voice in our initiatives.


If you want to get more involved, and see more of the opportunities we have for you (and all stakeholders) please check out the AiArthritis Voices Program. Unite with others around the world to talk, learn, and connect. 

Join AiArthritis Voices
Join the Conversation on Facebook!
Starting on March 1st at noon EST/USA visit our Facebook page to talk more with Tiffany and Bridget. They will focus on specific segments of the podcast episode and open the discussion up for your questions.

Show Notes - Episode 16: CBD

00:52 - Tiffany welcomes listeners and Bridget to the show

01:10 - Bridget Seritt founded Canna Patient Resource Connection, an organization that collects comprehensive patient information for therapeutic use of cannabis products

03:20 - Today’s topic will focus on CBD 

04:07 - Conversations will focus on the patient experience. Bridget is not a doctor and cannot prescribe medication. You should take information back to your health care provider and discuss treatment options with them.

05:59 - The widespread availability of CBD products is confusing for patients and doctors

06:50 - Prior to 1960, all hemp products were legally classified as marijuana. Definition was changed in response to industrial lobbying.

07:19 - The only difference between hemp and marijuana is the level of THC in it. 

07:28 - Federal definition of hemp is a plant that contains .3% or less THC.

10:24 - There are no standard definitions for broad spectrum, full spectrum, and isolate. But generally, full spectrum CBD contains all the cannabinoids, terpenes, and THC. Broad spectrum removes as much THC as possible. 

11:45 - THC is the part of cannabis that produces an intoxicating effect.

15:15 - Information about CBD is primarily available online and is generally being circulated by people who want to sell CBD or have a political agenda. It may not be accurate.

17:42 - One site Bridget reviewed claimed CBD was legal in all 50 states, but it failed to mention any potential legal problems it could create for people

19:16 - CBD was removed from the schedule of controlled substances, but it was transferred to the regulatory authority of the FDA which considers it a “drug product.”

19:37 - The 2018 Farm Bill that legalized hemp also contained a clause that said the bill did not prevent states from regulating further. So unless state laws have been modified to remove CBD from their own controlled substances list, you could be violating state law even if it is federally legal. 

21:34 - Using CBD would be a felony drug violation in South Dakota, even though it is totally legal in some other states.

23:24 - Always check with local municipalities for laws and regulations before beginning to use CBD.

23:40 - Canada allows all adults to use CBD, but they will not allow anyone to import it across the border.

24:10 - CBD isolates are legal in Idaho, but only ones made from hemp seeds and stalk. But CBD cannot be made from hemp seeds and stalk.

25:20 - In the United States, each state has a legal loophole that makes it illegal to give CBD to minors unless you participate in a state registry program. The Canna Patient Resource Connection has worked with four families recently who were in trouble with Child Protective Services for giving CBD to their child.

26:30 - In the US, mandated reporters, including teachers and doctors, are required by law to report you to CPS if you tell them that your child is taking CBD.

30:18 - The Arthritis Foundation surveyed people and found that over 70% were either interested in using CBD or already using it, so there is a lot of demand for accurate information about CBD.

34:19 - Very few patients experience relief immediately from taking CBD. It usually takes consistent use over time to see results.

37:12 - Cannabis has different effects at lower doses than it does at higher doses. Low doses tend to be more stimulatory, while higher doses tend to be more sedative.

37:38 - Some people may experience intoxication, so begin CBD therapy or increase your dose on a day when you do not need to be alert in case you experience a sedative effect.

40:48 - Oral CBD helps alleviate inflammation and neuropathic pain. Oral varieties are most comparable to extended release medications.

41:39 - Inhaled CBD via vaping is primarily recommended for acute symptoms.

42:39 - Vaping does not involve smoke or burning plant materials, and it is safe from reputable sources. Probably best for people with extreme nausea that do not have lung issues.

43:13 - Topical CBD products that include complementary essential oils are best. Entourage effects with topicals and essential oils are the most effective preparations for pain management.

46:07 - “Edibles” are a form of oral CBD where food is infused with CBD.

47:10 - Be wary of any commercial CBD infused products until you have researched them and seen lab testing. Most products infused with CBD are not going to be therapeutic.

47:59 - Avoid purchasing CBD from sources that you have not researched because there is no regulation currently in the US. Companies do not have to tell you what is in their product.

49:09 - Before you buy from a company, make sure that companies are batch testing every batch for THC content, solvent residues, heavy metals, and contaminants.

49:43 - Hemp is used to decontaminate soil. It will absorb many contaminants from the soil, so it is critically important that your CBD supplier be testing every batch for ground contaminants and heavy metals. Organic farming methods will not mitigate this risk.

51:18 - Always ask where a company is sourcing their hemp, and try to find a company that is using clean growing practices with local sourcing.

55:57 - Also ask what part of the plant is processed. You don’t want something from seeds or stalks. Ideally you want CBD sourced from flowers and some of the leaves.

53:48 - Look for a CBD that tells you how many mgs of CBD are in each mL of tincture, caplet, etc. so that you can regulate your dose for therapeutic purposes.

55:14 - Every oral drug that is metabolized by the cyp450 system will have some kind of drug interaction with CBD. 

55:22 - CBD also cancels out some drugs completely, independent of the aforementioned liver action.

55:35 - CBD will cause some drugs to have a stronger effect than intended.

55:53 - CBD does interact with opiate receptors, so always consult a pharmacist before taking any opiate with CBD due to the potential for a toxic effect.

56:50 - Just because CBD comes from a plant doesn’t mean it is safe to use in every situation.

57:20 - CBD for aiarthritis diseases should be used in conjunction with prescribed medications, not as a substitute for DMARDs or Biologics.

58:55 - Most doctors and nurses have not received any formal training on therapeutic uses for cannabis. 

1:01:43 - In states with legal medical cannabis programs, you can find a physician with cannabis training, and they should really be involved in your care decisions if you want to use therapeutic CBD.

1:03:09 - Visit the Canna Patient Resource Connection at keepitlegalcolorado.org for more information about therapeutic CBD use.

1:04:01 - Visit aiarthritis.org/podcast to continue the conversation about AiArthritis and CBD.

1:04:19 - Tiffany and Bridget will be hosting a Facebook event where you can ask questions about CBD. You can access that @IFAiArthritis on Facebook under the Event tab.


Patient Voices and All Other Stakeholders - Join our AiArthritis Voices Program and Connect to Opportunities to Have Your Voice Counted!


If you are a patient, a parent of a juvenile patient, or any other stakeholder (doctor, nurse, researcher, industry representative, or other health services person) - are you ready to join the conversation? It's your turn to pull up a seat. Join our new AiArthritis Voices program, where people living with AiArthritis diseases and other stakeholders who we need 'at the table' to solve problems that impact education, advocacy, and research sign up to have a voice in our initiatives. By signing up, you’ll get notified of opportunities to be more involved with this show - including submitting post-episode comments and gaining insider information on future show topics. Patients and all other stakeholders are encouraged to join so we can match you with opportunities to pull up a seat and TOGETHER - as equals - solve the problems of today and tomorrow.



JOIN TODAY! 

 

AiArthritis Voices 360 is produced by the International Foundation for Autoimmune and Autoinflammatory Arthritis. Visit us on the web at www.aiarthritis.org/talkshow. Find us on Twitter, Instagram, TikTok, or Facebook (@ifAiArthritis) or email us (podcast@aiarthritis.org).



Be sure to check out our top-rated show on  Feedspot!


Your Co-Hosts & Guests: Who is at the table this episode?

Bridget Dandaraw-Seritt

Bridget is a patient with multiple autoimmune diseases and genetic disorders. She is Co-Founder of Canna-Patient Resource Connection, an education and outreach organization that designs science-based cannabis education for beginners while working to improve support for moderate to severe patients using cannabis as therapy. Bridget is a published author and editorial consultant on cannabis patient issues, has served on several local and state cannabis work groups, and has presented at multiple industry events and conferences. Canna-Patient Resource Connection’s education is used nationwide by physicians, medical cannabis centers, and patient advocacy groups. 


Tiffany Westrich-Robertson

Tiffany is the CEO at International Foundation for AiArthritis and uses her professional expertise in mind-mapping and problem solving to help others, like her, who live with AiArthritis diseases work in unison to identify and solve unresolved community issues. For the last several years, she has continued her education in research, including becoming a professional focus group moderator, and translated this experience with our organization to develop award-winning, innovative projects that are taking patient engagement to next levels. 

Tiffany has served on several advisory boards, including those to advance patient voices in policy, clinical trials, and precision medicine. In addition to reviewing grants at PCORI and for the Department of Defense, she was the sole patient grant reviewer for the National Institute of Arthritis and Musculoskeletal and Skin diseases from 2015-2018. She currently participates as a Patient Research Partner for OMERACT (Outcome Measures in Rheumatology), co-leads our organization's international effort to advance patient voices in rheumatology research (the ACTion Council) and has dedicated her professional career to developing other patients to utilize their voices to impact the future of millions.

Love the show? Help us make sure we stay on the air by making a donation.


Your contribution helps us continue the work we do every day to improve the lives of millions worldwide.

Give Today!
Share by: